London – Application is supported by data from the Phase 3 CARTITUDE-4 study, which showed significant improvement in primary endpoint of progression-free survival (PFS) CARTITUDE-4 is the first randomized Phase 3 study investigating the efficacy of a cell therapy as early as after first relapse in multiple myeloma RARITAN, N.J., June 6, 2023 – The Janssen Pharmaceutical Companies of Johnson …
London – AstraZeneca has announced that its daily pill decreases deaths in lung cancer patients by half. The results were talked about at the American Society of Clinical Oncology in Chicago and published in the New England Journal of Medicine. The medication, known as osimertinib and marketed as Tagrisso, targets a particular receptor that promotes the growth of cancer cells. …
TORONTO- Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a long-term agreement with Ontario-based Novocol Pharma, a leading sterile injectable contract development and manufacturing organization (CDMO), to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines expected to be produced in Canada. Fill-finish sterile manufacturing is the final step in the production …
London – Updated results from the TROPION-Lung02 Phase Ib trial showed that, with additional enrolment and follow-up from the initial presentation, datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum-based chemotherapy demonstrated promising clinical activity and no new safety signals in both previously untreated or pretreated patients with advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations (AGAs). Results …
Washington – Ezra, an artificial intelligence (AI) powered cancer screener, Ezra, reported to be able to save life with early cancer detection, has received FDA clearance. It examines potential cancer in nearly 13 organs in a body using magnetic resonance imaging (MRI) technology and AI. Several other illnesses, such as fatty liver disease or brain aneurysms, can also be monitored …
Researchers, policy makers and people with lived experience will work together to help build more resilient, equitable, and inclusive health systems across Canada Ottawa – To prevent illness, treat disease, manage complex health conditions, and prepare for health emergencies, we need to strengthen our public and universal health care system. Innovative ways of doing research and integrating evidence into policy …
PEI to expand provincial drug coverage to make medication more affordable and accessible Charlottetown – No Canadian should have to choose between paying for prescription drugs and putting food on the table. Unfortunately, many are faced with this impossible decision every day. As part of the Improving Affordable Access to Prescriptions Drugs (IAAPD) program, supported by the Government of Canada, the Government …
Ottawa – On May 5, 2023, the World Health Organization (WHO) announced that COVID-19 is now an established and ongoing health issue and no longer constitutes a Public Health Emergency of International Concern (PHEIC). Even though the current COVID-19 situation no longer constitutes a global health emergency, vaccines remain the best line of defense as the virus is still circulating across Canada …
Washington – In a study, published in The American Journal of Clinical Nutrition, researchers said that daily multivitamin supplements, specifically Centrum Silver, may help slow age-related forgetfulness. They analysed the data of 3,500 older participants who took multivitamins for three years. It was found that they had better memories than those who received a placebo treatment.
Washington – The US is facing widespread shortages of cancer drugs. As a result the doctors are rationing doses and turning to other treatment options that may have severer side effects. Food and Drug Administration (FDA) has listed 14 cancer drugs in shortage in the US. Between 2021 and 2022, there was an “almost 30% increase in new medicine shortages.” …
